This patient-focused webinar will explore the fundamentals of ATTR amyloidosis, offering participants a clear understanding of the condition and its impact on health. Attendees will learn to distinguish between hereditary and wild-type forms of ATTR amyloidosis and recognize common symptoms that may lead to diagnosis. The session will also highlight the importance of early detection and provide an overview of current treatment options and emerging therapies that offer hope for improved outcomes.
Key Takeaways
After this webinar, you will have a better understanding of:
- Understand the basics of ATTR Amyloidosis
- Define ATTR Amyloidosis and differentiate between hereditary and wild-type forms
- Recognize symptoms and the importance of early diagnosis
- Explore treatment options and emerging therapies
Audience
Any patient or caregiver who wishes to understand more about heart failure treatment and management, engage in conversations around improving conditions, and discover educational resources from HFSA and partnering patient and provider organizations.